News Search Results
Mar 22, 2026, 20:00 ET Innovent Announces First Participant Dosed of IBI128 (Tigulixostat, XOI) in Phase 3 Clinical Study
that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announced that the xanthine oxidase inhibitor (XOI) Tigulixostat(R&D code: IBI128) have the first participant dosed
More news about: Innovent Biologics
Mar 19, 2026, 14:34 ET CSA's East Bay Surgery Center and Orthopedic Associates Surgery Center Add U.S. News & World Report's "Best Ambulatory Surgery Centers" to Their Growing List of National Honors
East Bay Surgery Center, an AAAHC-accredited facility in Swansea, Massachusetts, was recognized in the Best Ophthalmology category for a third consecutive year. Orthopedic Associates Surgery Center (OASC), an AAAHC-accredited facility in Rocky Hill, Connecticut, was
More news about: Constitution Surgery Alliance
Mar 19, 2026, 11:15 ET Keyboardist for X Ambassadors, Casey Harris, Partners with Vision Through Music Program® to Expand Music Education Access for Visually Impaired Children
announced a new partnership with Vision Through Music®, a program of the Children's Eye Foundation of the American Association for Pediatric Ophthalmology and Strabismus (CEF of AAPOS). "Having Casey Harris join Vision Through Music is a gamechanger for our program," said Bradley Black, MD,
More news about: Children's Eye Foundation and American Association for Pediatric Ophthalmology and Strabismus
Mar 19, 2026, 08:17 ET NIPER Raebareli partners with Roche Pharma to Strengthen Pharmaceutical Education and Research Capability Building Collaboration
Basel, Switzerland. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. For more information on Roche Pharma India, visit
More news about: Roche Products (India) Pvt. Ltd
Mar 19, 2026, 03:38 ET Animal Regenerative Therapies Market Worldwide to Reach USD 870 Million by 2032, Driven by Advancements in Veterinary Biotechnology | Vyansa Intelligence
& Ligament Injuries, Fractures, Joint Disorders), Wound Healing, Cardiovascular Conditions, Neurological Disorders, Dermatological Conditions, Ophthalmology, Dental Applications, OthersBy End User: Veterinary Hospitals & Clinics, Veterinary Research Institutes, Academic & Research
More news about: Vyansa Intelligence
Mar 17, 2026, 03:00 ET MemorialCare Named Best Ambulatory Surgery Centers in U.S. News & World Report Third Year in a Row
U.S. News & World Report rated over 4,400 surgery centers in three separate specialty areas: Colonoscopy, Endoscopy and OphthalmologyFOUNTAIN VALLEY, Calif., March 17, 2026 /PRNewswire/ -- Two of
More news about: MemorialCare
Mar 17, 2026, 00:01 ET U.S. News & World Report Names 2026 Best Ambulatory Surgery Centers
serve as a vital resource for the millions of Americans opting for same-day surgical care in specialties including Colonoscopy & Endoscopy, Ophthalmology, Orthopedics & Spine and Urology.
More news about: U.S. News & World Report, L.P.
Mar 16, 2026, 09:18 ET ONL Therapeutics Announces First European Patient Randomized in its Global Phase 2 GALAXY Trial of Xelafaslatide (ONL1204) in Patients with Geographic Atrophy (GA) Associated with Dry AMD
enrolling approximately 324 patients across Europe, Canada and the U.S. "Geographic atrophy remains one of the most devastating challenges in ophthalmology, and treatment options in Europe remain limited," said David N. Zacks, M.D., Ph.D., chief scientific officer of ONL Therapeutics. "With its unique
More news about: ONL Therapeutics
Mar 16, 2026, 08:00 ET Celltrion announces U.S. availability of AVTOZMA® (tocilizumab-anoh) subcutaneous (SC) formulation
monoclonal antibody biosimilar. Our global pharmaceutical portfolio addresses a range of therapeutic areas including immunology, oncology, hematology, ophthalmology and endocrinology. Beyond biosimilar products, we are committed to advancing our pipeline with novel drugs to push the boundaries of scientific
More news about: Celltrion
Mar 16, 2026, 07:00 ET Keenova Therapeutics to Report Fourth-Quarter 2025 Financial Results on March 31, 2026
diversified brands portfolio, which is focused across a wide range of therapeutic areas of significant unmet need. These include rheumatology, ophthalmology, orthopedics, urology, neonatal respiratory critical care, nephrology, neurology, and pulmonology.Globally headquartered in Dublin, Ireland,
More news about: Keenova Therapeutics
Mar 16, 2026, 07:00 ET Sun Pharma Announces US FDA Acceptance of Supplemental Biologics License (sBLA) Application for ILUMYA® (tildrakizumab-asmn) for the Treatment of Adults with Active Psoriatic Arthritis
U.S. as well as global Emerging Markets. Sun Pharma's high-growth global Innovative Medicines portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for about 20% of company sales. The company's vertically integrated operations deliver high-quality medicines,
More news about: Sun Pharmaceutical Industries Inc., USA (Sun Pharma)
Mar 16, 2026, 05:54 ET Everest Medicines to Announce 2025 Full-Year Financial Results on March 26, 2026 and Hold Online Earnings Call
global pharmaceutical companies.The Company's therapeutic areas of focus include CKM (cardiovascular, kidney, and metabolic), autoimmune, ophthalmology and critical care. Everest Medicines has developed a fully integrated commercialization platform that combines omnichannel commercial capabilities
More news about: Everest Medicines
Mar 16, 2026, 05:31 ET Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Solutions
Mar 16, 2026, 05:27 ET Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch
associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics
More news about: Piramal Pharma Solutions
Mar 13, 2026, 07:00 ET InMode Announces New Share Repurchase Program
technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com/.Forward-Looking
More news about: InMode Ltd.
Mar 13, 2026, 06:06 ET 雲頂新耀合作夥伴新橋生物與Visara宣佈VIS-101 IIa期臨床在濕性AMD取得積極頂線數據
信息來源：1.《眼科研究與視覺科學（Investigative Ophthalmology & Visual Science）》，2021年11月24日；第62卷（14期）：第26頁。doi：10.1167/iovs.62.14.26關於雲頂新耀雲頂新耀是一
More news about: 雲頂新耀
Mar 11, 2026, 11:21 ET AI Adoption Accelerates Across Eyecare as IntelePeer's SmartAgent Gains Momentum with Multi-Site Practices
/PRNewswire/ -- AI is quickly becoming a foundational tool for eyecare practices seeking to reduce administrative burden and improve access to care. As ophthalmology and optometry organizations move beyond experimentation toward real-world deployment, IntelePeer is seeing increased adoption of its Smart™ Suite
More news about: IntelePeer
Mar 11, 2026, 11:00 ET Epidemiology Database: DelveInsight Unveils AI-Powered Platform Analyzing Patient Burden and Forecasts Across 500+ Diseases
DelveEpiAI Features a vast repository spanning multiple therapeutic areas, including Oncology, Immunology, Respiratory, Dermatology, Ophthalmology, Neurology, Women's Health, and many others, with insights into highly active clinical trial pipelines.Includes extensive coverage of rare
More news about: DelveInsight Business Research, LLP
Mar 11, 2026, 08:09 ET HelpMeSee Featured in "Healthier Together," Presented by the WHO Foundation, Highlighting Efforts to Reduce Cataract Blindness Through Surgical Training
surgical training in areas where the need is greatest.With the generous support of Dr. Nayana Potdar, Professor and Head of the Department of Ophthalmology, and Dr. Shailesh Mohite, Dean and Director of Medical Health and Medical Education at Topiwala National Medical College, BYL Nair Hospital in Mumbai,
More news about: HelpMeSee
Mar 11, 2026, 08:09 ET HelpMeSee Featured in "Healthier Together," Presented by the WHO Foundation, Highlighting Efforts to Reduce Cataract Blindness Through Surgical Training
surgical training in areas where the need is greatest.With the generous support of Dr. Nayana Potdar, Professor and Head of the Department of Ophthalmology, and Dr. Shailesh Mohite, Dean and Director of Medical Health and Medical Education at Topiwala National Medical College, BYL Nair Hospital in Mumbai,
More news about: HelpMeSee
Mar 10, 2026, 09:00 ET Verana Health Enhances World Renowned RWD Ophthalmic Registry with Images
expansion of the IRIS Registry Analytics Consortium founded in 2017 in collaboration with AMC members that has streamlined the sharing of complex ophthalmology RWD to advance scientific discovery. This data expansion initiative is focused on enabling research of traditionally difficult to access image modalities.
More news about: Verana Health
Mar 10, 2026, 09:00 ET Imre selects Fred Hickman III as EVP to lead Account Services
career, and most recently with Klick, Fred has led brand strategy and market development initiatives across rare disease, pediatrics, dermatology, ophthalmology, autoimmune, neurological, and medical devices among other categories, here in the US and around the globe, consistently balancing operational excellence
More news about: Imre
Mar 10, 2026, 06:16 ET Everest Medicines to Announce 2025 Full-Year Financial Results on March 26, 2026
global pharmaceutical companies.The Company's therapeutic areas of focus include CKM (cardiovascular, kidney, and metabolic), autoimmune, ophthalmology and critical care. Everest Medicines has developed a fully integrated commercialization platform that combines omnichannel commercial capabilities
More news about: Everest Medicines
Mar 10, 2026, 04:00 ET Ambient Scientific powers new 'MAI' women's safety wearable, enabling always-on AI and two-week battery life
solutions for both B2B and B2C markets. The company develops disease-specific foundation models, tuned across specialities such as dermatology, ophthalmology, neurology, and oncology to convert longitudinal biometrics, lifestyle context, and medical history into actionable insights for prevention, screening,
More news about: Ambient Scientific
Mar 07, 2026, 05:10 ET Best Stylish Sunglasses for Women (2026): Quay Selected for Fashion-Forward Frames by Consumer365
wardrobesInterest in protective eyewear continues to grow as awareness of long term eye health increases. According to the American Academy of Ophthalmology, sunglasses should block 99 to 100 percent of UVA and UVB rays to help reduce the risk of sun related eye damage. This recommendation remains a
More news about: Consumer365.org